CompanyGraph
Jiangsu Hanbon Science & Technology Co., Ltd.
688755 · SSE · China
hanbon.com.cnFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 4.16: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.80%
Annual Rate
CNY 0.24Paid semi-annual
Payout Ratio
29.6%Sustainable
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.42BCNY510.59M · vs all stocks (USD)
Trailing P/E
42.12xvs Medical Devices peers
Revenue (TTM)
804.01MCNY120.01M · vs all stocks (USD)
Profit Margin
9.48%vs Medical Devices peers
52-Week Change
-15.59%vs all stocks
Forward Annual Dividend Yield
0.80%vs all stocks
Market Capitalization
3.42BCNY510.59M · vs all stocks (USD)
Enterprise Value
2.26BCNY337.22M · vs all stocks (USD)
Trailing P/E
42.12xvs Medical Devices peers
Forward P/E
29.89xvs Medical Devices peers
Price to Sales (TTM)
3.96xvs Medical Devices peers
Price to Book (MRQ)
2.47xvs Medical Devices peers
Enterprise to Revenue
2.81xvs Medical Devices peers
Enterprise to EBITDA
26.49xvs Medical Devices peers
Gross Margin
36.45%vs Medical Devices peers
Profit Margin
9.48%vs Medical Devices peers
Operating Margin
6.42%vs Medical Devices peers
Return on Assets (TTM)
2.21%vs Medical Devices peers
Return on Equity (TTM)
6.12%vs Medical Devices peers
Revenue (TTM)
804.01MCNY120.01M · vs all stocks (USD)
Revenue per Share (TTM)
7.04CNYUpdated Sep 22, 2026Quarterly Revenue Growth
21.50%vs Medical Devices peers
Gross Profit (TTM)
257.07MCNY38.37M · vs all stocks (USD)
EBITDA (TTM)
121.87MCNY18.19M · vs all stocks (USD)
Net Income (TTM)
76.25MCNY11.38M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
55.40%vs Medical Devices peers
Operating Cash Flow (TTM)
185.33MCNY27.66M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
98.51MCNY14.70M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2400CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.80%vs all stocks
Trailing Annual Dividend Rate
0.1969CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.66%vs all stocks
Payout Ratio
29.63%vs Medical Devices peers
Revenue
735.13MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
473.65MCNYFY2025 · Dec 31, 2025Gross Profit
261.48MCNYFY2025 · Dec 31, 2025Operating Income
96.46MCNY14.40M · vs all stocks (USD)
Pre-tax Income
69.28MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.63MCNYFY2025 · Dec 31, 2025Net Income
59.65MCNYFY2025 · Dec 31, 2025EBIT
69.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
121.87MCNYFY2025 · Dec 31, 2025Research & Development
45.29MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
53.65MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
209.43KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5846CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5846CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
102.04MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
102.04MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
59.65MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-47.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
-143.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
722.29MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
59.65MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.88MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-88.70MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-25.27MCNYFY2025 · Dec 31, 2025Capital Expenditures
-96.21MCNYFY2025 · Dec 31, 2025Purchase of Investments
-308.00MCNYFY2025 · Dec 31, 2025Sale of Investments
143.40MCNYFY2025 · Dec 31, 2025Other Investing Activity
100.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-260.70MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
9.05MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-24.05MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.06MCNYFY2025 · Dec 31, 2025Other Financing Charges
435.68MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
411.62MCNYFY2025 · Dec 31, 2025Shares Outstanding
114.40MSharesUpdated Sep 22, 2026Float Shares
54.53MSharesUpdated Sep 22, 2026% Held by Insiders
53.31%vs all stocks
% Held by Institutions
8.08%vs all stocks
Total Cash (MRQ)
924.65MCNY138.02M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.08CNYUpdated Sep 22, 2026Total Debt (MRQ)
3.42MCNY511.14K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0027xvs Medical Devices peers
Current Ratio (MRQ)
2.27xvs Medical Devices peers
Book Value per Share (MRQ)
11.23CNYUpdated Sep 22, 2026Total Assets
1.94BCNY289.38M · vs all stocks (USD)
Total Current Assets
1.58BCNYFY2025 · Dec 31, 2025Total Liabilities
695.81MCNYFY2025 · Dec 31, 2025Total Non-current Assets
363.13MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
49.27MCNYFY2025 · Dec 31, 2025Total Current Liabilities
646.54MCNYFY2025 · Dec 31, 2025Cash
722.29MCNYFY2025 · Dec 31, 2025Cash Equivalents
28.46MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
750.75MCNYFY2025 · Dec 31, 2025Other Short-term Investments
165.23MCNYFY2025 · Dec 31, 2025Accounts Receivable
185.28MCNYFY2025 · Dec 31, 2025Inventory
376.53MCNYFY2025 · Dec 31, 2025Accounts Payable
252.66MCNYFY2025 · Dec 31, 2025Short-term Debt
3.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
29.15MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.32MCNYFY2025 · Dec 31, 2025Common Stock (Book)
88.00MCNYFY2025 · Dec 31, 2025Retained Earnings
188.43MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.24BCNY185.52M · vs all stocks (USD)
52-Week Low
21.89CNYUpdated Sep 22, 202652-Week High
36.07CNYUpdated Sep 22, 202652-Week Change
-15.59%vs all stocks
50-Day MA
25.78CNYUpdated Sep 22, 2026200-Day MA
28.77CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.33MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.30MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.6600CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.16: safe zoneNotable
Altman Z-Score: 4.16
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Bright Minds Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ever Supreme Bio Technology Co., Ltd
Tier 1ProductionApproval-Gated PipelineRuleFlow
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Careray Digital Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tactile Systems Technology Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Sd Biosensor Inc.
Tier 1ProductionApproval-Gated PipelineRule
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule